114 related articles for article (PubMed ID: 33355860)
1. Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium.
Buchynska LG; Borykun TV; Iurchenko NP; Nespryadko SV; Nesina IP
Exp Oncol; 2020 Dec; 42(4):289-294. PubMed ID: 33355860
[TBL] [Abstract][Full Text] [Related]
2. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
[TBL] [Abstract][Full Text] [Related]
3. Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma.
Montserrat N; Mozos A; Llobet D; Dolcet X; Pons C; de Herreros AG; Matias-Guiu X; Prat J
Hum Pathol; 2012 May; 43(5):632-43. PubMed ID: 21940036
[TBL] [Abstract][Full Text] [Related]
4. Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers.
Kalinkova L; Kajo K; Karhanek M; Wachsmannova L; Suran P; Zmetakova I; Fridrichova I
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842533
[TBL] [Abstract][Full Text] [Related]
5. microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.
Devor EJ; Hovey AM; Goodheart MJ; Ramachandran S; Leslie KK
Oncol Rep; 2011 Oct; 26(4):995-1002. PubMed ID: 21725615
[TBL] [Abstract][Full Text] [Related]
6. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis.
Romero-Pérez L; Castilla MÁ; López-García MÁ; Díaz-Martín J; Biscuola M; Ramiro-Fuentes S; Oliva E; Matias-Guiu X; Prat J; Cano A; Moreno-Bueno G; Palacios J
Hum Pathol; 2013 Feb; 44(2):244-54. PubMed ID: 22974476
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
Zhang X; Dong Y; Ti H; Zhao J; Wang Y; Li T; Zhang B
Hum Pathol; 2013 Nov; 44(11):2571-80. PubMed ID: 24071015
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2.
Shang C; Lu YM; Meng LR
Med Sci Monit; 2012 Apr; 18(4):BR149-55. PubMed ID: 22460089
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.
Chung TK; Cheung TH; Huen NY; Wong KW; Lo KW; Yim SF; Siu NS; Wong YM; Tsang PT; Pang MW; Yu MY; To KF; Mok SC; Wang VW; Li C; Cheung AY; Doran G; Birrer MJ; Smith DI; Wong YF
Int J Cancer; 2009 Mar; 124(6):1358-65. PubMed ID: 19065659
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
11. MiRNAs in endometrioid endometrial cancer metastatic loci derived from positive lymph nodes.
Wilczynski M; Senderowska D; Krawczyk T; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1085-1091. PubMed ID: 32100871
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of miR-203 in endometrial carcinomas.
Huang YW; Kuo CT; Chen JH; Goodfellow PJ; Huang TH; Rader JS; Uyar DS
Gynecol Oncol; 2014 May; 133(2):340-5. PubMed ID: 24530564
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer.
Kumari P; Sharma I; Saha SC; Srinivasan R; Minhas P
J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556
[TBL] [Abstract][Full Text] [Related]
14. Verification of microRNA expression in human endometrial adenocarcinoma.
Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
[TBL] [Abstract][Full Text] [Related]
15. Expression of chemokine receptor CXCR4 in tumor cells and content of CXCL12
Buchynska LG; Movchan OM; Iurchenko NP
Exp Oncol; 2021 Jun; 43(2):135-141. PubMed ID: 34190517
[TBL] [Abstract][Full Text] [Related]
16. miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer.
Fridrichova I; Kalinkova L; Karhanek M; Smolkova B; Machalekova K; Wachsmannova L; Nikolaieva N; Kajo K
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374439
[TBL] [Abstract][Full Text] [Related]
17. Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression.
Westin SN; Broaddus RR; Deng L; McCampbell A; Lu KH; Lacour RA; Milam MR; Urbauer DL; Mueller P; Pickar JH; Loose DS
Cancer Biol Ther; 2009 Nov; 8(22):2126-35. PubMed ID: 19755863
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
BMC Cancer; 2012 Aug; 12():369. PubMed ID: 22920721
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
[TBL] [Abstract][Full Text] [Related]
20. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
